Shareholders meeting

Bliss GVS Pharma Limited announced its 41st Annual General Meeting (AGM) will be held on July 15, 2026, via Video Conference. Key agenda items include the adoption of the audited financial statements for FY2025-2026, the proposed declaration of a final dividend of 100% (INR 1.00 per equity share), and the re-appointment of Mr. Narsimha Shibroor Kamath as Managing Director & CEO. The record date for the dividend is set for July 08, 2026, with payment expected by August 14, 2026, if approved.